Tekla Capital Management LLC Theseus Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Theseus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 75,000 shares of THRX stock, worth $0. This represents 0.03% of its overall portfolio holdings.

Number of Shares
75,000
Previous 75,000 -0.0%
Holding current value
$0
Previous $666,000 4.95%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$5.21 - $14.05 $130,250 - $351,250
-25,000 Reduced 25.0%
75,000 $666,000
Q4 2021

Feb 14, 2022
BUY
$8.98 - $20.09 $898,000 - $2.01 Million
100,000 New
100,000 $1.27 Million

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email